Triangle drug firm Novan subsidiary lands $5M upfront in licensing deal

EPI Health, a subsidiary of Durham-based pharmaceutical firm Novan, has landed a licensing deal with Japan-based Sato Pharmaceuticals for a facial treatment.

Read More